Original Source(s)
Related Content
Weekly HIV Therapy Meets Primary Endpoint
Patients who switched from daily antiretroviral therapy maintained virologic suppression in two phase 3 trials.
July 23, 2026
-
3 min
Top 10 CDC Updates Physicians Should Know
Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.
July 9, 2026
-
6 min
FDA Grants Traditional Approval to Iptacopan in Primary IgAN
Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.
July 17, 2026
-
2 min
